Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $550,000 in previously unannounced orders of QS-H150 and QS-B220s to multiple customers in North America, Europe, Middle East, and Africa.
Customers for the handheld and desktop explosives trace detectors include a major international logistics corporation, a construction company, an airport, and the embassy of a foreign nation. The systems will be used for building security and for the screening of air cargo, and airline passengers and baggage.
"The regulatory certifications we have received so far for our products have established a strong foothold for the Company in aviation security. Adding cargo, passenger, and baggage screening to our existing markets like building security, subways, and critical infrastructure has been an important part of our ability to significantly increase orders received as compared to the the previous year. We anticipate that success in the approval efforts we have underway at the moment will strongly accelerate this trend," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.
About the QS-H150 Handheld Explosives Trace Detector
The QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.
About the QS-B220 Desktop Explosives and Drugs Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
Source: http://www.implantsciences.com/